Health Care·Life Sciences Tools & Services·$174.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.17 | N/A | +5.88% |
management commentary, guidance changes, and full analysis available with Pro.
| +5.88% |
Tone: Cautiously Optimistic
Management expressed satisfaction with the earnings beat and emphasized their commitment to innovation. They highlighted the importance of customer relationships in driving future growth.
We are pleased with our performance this quarter.
Our focus remains on innovation and customer satisfaction.
Thermo Fisher Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock rose by 4.42% in response, reflecting investor confidence in the company's performance. However, the lack of revenue data and guidance leaves some uncertainty about future growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CANADIAN NATL RY CO
Apr 23, 2012